Pages that link to "Q43215090"
Jump to navigation
Jump to search
The following pages link to Electroconvulsive therapy decreases dopamine D₂receptor binding in the anterior cingulate in patients with depression: a controlled study using positron emission tomography with radioligand [¹¹C]FLB 457. (Q43215090):
Displaying 15 items.
- A Review of Longitudinal Electroconvulsive Therapy: Neuroimaging Investigations (Q22299257) (← links)
- Molecular imaging for depressive disorders (Q30821361) (← links)
- The use of ECT and MST in treating depression (Q37971397) (← links)
- Positron emission tomography in psychiatric disorders (Q37975237) (← links)
- Molecular Neurobiology of Depression: PET Findings on the Elusive Correlation with Symptom Severity (Q38086422) (← links)
- Do certain signal transduction mechanisms explain the comorbidity of epilepsy and mood disorders? (Q38182769) (← links)
- Pharmacogenetics in electroconvulsive therapy and adjunctive medications. (Q38538621) (← links)
- Potential Mechanisms Underlying the Therapeutic Effects of Electroconvulsive Therapy. (Q38776732) (← links)
- Structural-functional brain changes in depressed patients during and after electroconvulsive therapy. (Q39162637) (← links)
- Dcc haploinsufficiency regulates dopamine receptor expression across postnatal lifespan (Q39302600) (← links)
- Electroconvulsive Treatment: Hypotheses about Mechanisms of Action (Q42571513) (← links)
- Unilateral ultra-brief pulse electroconvulsive therapy for depression in Parkinson's disease (Q48053905) (← links)
- A randomised, placebo-controlled trial of transcranial pulsed electromagnetic fields in patients with multiple chemical sensitivity (Q60606791) (← links)
- Decoding the Mechanism of Action of Rapid-Acting Antidepressant Treatment Strategies: Does Gender Matter? (Q64111576) (← links)
- Antidepressant treatment effects on dopamine transporter availability in patients with major depression: a prospective 123I-FP-CIT SPECT imaging genetic study (Q87866264) (← links)